Douglas Lauffenburger

Professor
Department
Department of Biological Engineering
Technology Areas
Biomaterials & Bioelectronics: Health Monitoring / Diagnostics: Assays / Drug Discovery and Research Tools: Cell Culture, Cell Interrogation, Genomics & Proteomics, Cell Lines & Organoids / Biotechnology: DNA & RNA Editing / Therapeutics: Small Molecules, Cell Based Therapy, Regenerative Medicine
Impact Areas
Healthy Living

Technologies

Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-Negative Breast Cancer

Technology / Case number: #16742
Aaron Meyer / Miles Miller / Madeleine Oudin / Linda Griffith / Douglas Lauffenburger / Frank Gertler
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

RNAI-Based Method of Screening and Characterizing Drug Combinations

Technology / Case number: #19756
Michael Hemann / Justin Pritchard / Douglas Lauffenburger
Technology Areas: Biotechnology / Drug Discovery and Research Tools
Impact Areas: Healthy Living
License

Multiplexed Specific Metalloprotease Activity Measurements

Technology / Case number: #19425DE
Miles Miller / Caroline Chopko Ahrens / Christi Cook / Steven Tannenbaum / Ravindra Kodihalli / Evan Chiswick / Linda Griffith / Douglas Lauffenburger
Technology Areas: Biomaterials & Bioelectronics / Diagnostics / Drug Discovery and Research Tools
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up